Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
6 employees
Calyx Therapeutics: Specialized physical therapy provider for orthopedic and pelvic pain.
HQ
Founded
1997
Calyx Therapeutics was founded with the core mission of providing specialized physical therapy services that go beyond mere pain relief. The company focuses on addressing both orthopedic complaints and pelvic pain, aiming to improve overall body function and quality of life. Their vision is to offer evidence-based care tailored to each patient's unique situation, helping them reclaim motion and vibrant function. Calyx Therapeutics serves patients by offering compassionate and thoughtful strategies to ensure they can return to their daily activities and work.
Notable affiliated individuals include experienced physical therapists who specialize in orthopedic and pelvic pain treatment. Key achievements of Calyx Therapeutics include successfully helping numerous patients regain mobility and improve their quality of life through personalized therapy plans. The overall impact of the organization is reflected in its commitment to holistic patient care, emphasizing the importance of treating the root cause of pain and its effects on the entire body.
Operating Status
Active
Main Product(s)
Physical Therapy
Tags
Healthtech
Model Types
Professional Services
Revenue Type(s)
Consulting
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Calyx Therapeutics founded?
Calyx Therapeutics was founded in 1997.
Where is Calyx Therapeutics's headquarters located?
Calyx Therapeutics's headquarters is located in San Francisco, CA, US.
When was Calyx Therapeutics's last funding round?
Calyx Therapeutics's most recent funding round was for $30M (USD) in December 2001.
How many employees does Calyx Therapeutics have?
Calyx Therapeutics has 6 employees as of Feb 4, 2024.
How much has Calyx Therapeutics raised to-date?
As of July 05, 2023, Calyx Therapeutics has raised a total of $30M (USD) since Dec 7, 2001.
Add Comparison
Total Raised to Date
$30M
USD
Last Update Dec 7, 2001
Last Deal Details
$30M
USD
Dec 7, 2001
Series D
Current Employees
6
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts